BARBIERI, Maria Antonietta
 Distribuzione geografica
Continente #
EU - Europa 2.166
NA - Nord America 1.607
AS - Asia 1.244
SA - Sud America 351
AF - Africa 53
OC - Oceania 6
Totale 5.427
Nazione #
US - Stati Uniti d'America 1.544
RU - Federazione Russa 1.336
SG - Singapore 545
BR - Brasile 289
CN - Cina 269
IT - Italia 178
IE - Irlanda 149
HK - Hong Kong 148
SE - Svezia 126
DE - Germania 76
VN - Vietnam 72
IN - India 68
PL - Polonia 52
FR - Francia 47
CA - Canada 36
GB - Regno Unito 35
FI - Finlandia 34
EE - Estonia 32
IQ - Iraq 22
BD - Bangladesh 21
NL - Olanda 20
AR - Argentina 17
MX - Messico 17
ZA - Sudafrica 17
JP - Giappone 14
TR - Turchia 14
ES - Italia 13
BE - Belgio 12
ID - Indonesia 12
MA - Marocco 11
UA - Ucraina 11
AT - Austria 10
CO - Colombia 10
EC - Ecuador 10
CL - Cile 9
CI - Costa d'Avorio 6
PK - Pakistan 6
VE - Venezuela 6
LT - Lituania 5
TH - Thailandia 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
EG - Egitto 4
LB - Libano 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
PY - Paraguay 4
SA - Arabia Saudita 4
TW - Taiwan 4
UY - Uruguay 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
DZ - Algeria 3
JO - Giordania 3
KZ - Kazakistan 3
NO - Norvegia 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
CR - Costa Rica 2
GE - Georgia 2
IL - Israele 2
KE - Kenya 2
LV - Lettonia 2
NP - Nepal 2
PT - Portogallo 2
SN - Senegal 2
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CD - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LY - Libia 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PW - Palau 1
RO - Romania 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TO - Tonga 1
TZ - Tanzania 1
Totale 5.427
Città #
Ashburn 362
Moscow 359
Singapore 343
Dallas 229
Chandler 161
Dublin 148
Hong Kong 148
Beijing 90
San Jose 90
Nyköping 65
The Dalles 55
Los Angeles 52
Messina 52
Warsaw 48
Munich 38
São Paulo 28
New York 24
Hyderabad 22
Frankfurt am Main 21
Lauterbourg 21
Turku 21
Ho Chi Minh City 20
Princeton 19
Rome 19
Medford 18
Orem 18
Santa Clara 18
Tianjin 17
Buffalo 15
Redondo Beach 15
Seattle 14
Amsterdam 13
Denver 13
Hanoi 13
Brooklyn 12
Brussels 12
Dearborn 12
Des Moines 12
Guangzhou 12
Montreal 12
Baghdad 11
Catania 11
Chennai 11
Belo Horizonte 10
Council Bluffs 10
Jacksonville 10
Stockholm 10
Tokyo 10
London 9
Paternò 9
Rio de Janeiro 9
Shanghai 9
Helsinki 8
Jakarta 8
Mumbai 8
Vienna 8
Wilmington 8
Boston 7
Johannesburg 7
Mexico City 7
Milan 7
Pune 7
Salvador 7
Abidjan 6
Bremen 6
Houston 6
Nuremberg 6
Santiago 6
Toronto 6
Atlanta 5
Bexley 5
Changsha 5
João Pessoa 5
Lamezia Terme 5
Manchester 5
New Delhi 5
Shenzhen 5
Bari 4
Boardman 4
Brno 4
Calgary 4
Campinas 4
Columbus 4
Coronel Fabriciano 4
Dong Ket 4
Istanbul 4
Medellín 4
Miami 4
Montevideo 4
Muscat 4
Ottawa 4
Pittsburgh 4
Poplar 4
Riyadh 4
Amman 3
Baku 3
Beirut 3
Brasília 3
Campos dos Goytacazes 3
Charlotte 3
Totale 3.024
Nome #
Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude 225
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 223
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 216
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database 197
Anticancer and anti-inflammatory properties of ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment 191
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 183
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 172
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care 171
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 171
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 167
Clinically Relevant Drug Interactions Between Statins and Antidepressants 164
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 159
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 156
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 147
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice 143
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 143
Effectiveness and safety profile of dupilumab in chronic Rhinosinusitis with nasal polyps: real-life data in tertiary care 141
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 141
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study 135
Clinically relevant drug interactions between newer antidepressants and oral anticoagulants 130
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents 130
Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register 124
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System 115
Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance 110
Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience 110
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 107
Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System 103
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System 93
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues 88
Management of patients with inflammatory bowel diseases: evaluating effectiveness, safety, and drug repurposing strategies 86
The intertwining of healthcare-associated infections and COVID-19 in Italian intensive care units: an analysis of the SPIN-UTI project from 2006 to 2021 85
Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia 80
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database 74
Artificial intelligence for the optimal management of community-acquired pneumonia 73
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023) 72
Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points 71
Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy 68
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System 65
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System 64
Drug Repurposing in Crohn’s Disease Using Danish Real-World Data 59
Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database 55
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data 52
Network Analysis and Machine Learning for Signal Detection and Prioritization Using Electronic Healthcare Records and Administrative Databases: A Proof of Concept in Drug-Induced Acute Myocardial Infarction 46
Drug Safety and Relevant Issues in the Real-World 44
Timing Matters: A Machine Learning Method for the Prioritization of Drug–Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure 38
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review 33
Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention 28
A newly developed method for assessing co-exposure to free dose combinations: a proof-of-concept study using antihypertensive medications in Danish registers 26
null 22
Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience 20
Artificial intelligence in pharmacovigilance signal management: a review of tools, implementations, research, and regulatory landscape 17
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 14
Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders 6
Factors Associated with Parental Vaccine Hesitancy in Childhood Immunization: Insights from a Cross-Sectional Survey in Southern Italy 1
Totale 5.554
Categoria #
all - tutte 16.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 23 0 4
2021/2022168 5 13 0 2 10 9 8 7 0 47 5 62
2022/2023476 33 56 20 51 26 43 7 49 174 1 14 2
2023/2024185 12 16 23 13 12 33 19 8 4 25 6 14
2024/20251.143 21 17 28 72 37 54 68 188 228 121 152 157
2025/20263.424 223 177 303 261 286 612 434 486 455 187 0 0
Totale 5.554